The FY24 Defense Appropriations Act is anticipated to provide funding for the BCRP to support innovative, high-impact research with clinical relevance that will accelerate progress to end breast cancer for Service Members and their Families, Veterans, and the general public.
The Translational Genomics Research Institute, part of City of Hope, established a fellowship in glioblastoma multiforme research. The Lori Lane/Andrew Spyrow Fellowship honors the lives of Lori Lane and Andrew Spyrow who fought GBM bravely, teaching all of us to experience the joy of life and dedicating their journey to the advancement of treatment improving the quality and longevity of life for those facing this devastating cancer.
MIB Agents, a pediatric osteosarcoma nonprofit, is accepting applications for its annual OutSmarting Osteosarcoma research grant program. This program was established in 2017 and is awarded to projects focused on moving research forward for osteosarcoma patients.
FDA is accepting applications for its Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01). This program is administered by the FDA’s Office of Orphan Products Development.
NCI intends to publish a Notice of Funding Opportunity for the NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research.
The application period for the DKMS John Hansen Research Grant 2024 began Aug. 1.
The FY23 Defense Appropriations Act provides funding for the Pancreatic Cancer Research Program (PCARP) to support research of exceptional scientific merit and innovation with high impact that focuses on pancreatic cancer.
Society for Immunotherapy of Cancer is seeking the scientists to continue Steven A. Rosenberg’s legacy with a research award specifically for early career scientists focused on tackling challenges that face the field of immunology and cancer immunotherapy.
Harrington Discovery Institute at University Hospitals is now accepting letters of intent for the 2024 Harrington Scholar-Innovator Award for physician-scientists.
The FY23 Defense Appropriations Act provides funding for the Rare Cancers Research Program to support research of exceptional scientific merit in the area of rare cancers research.
